SCHEMBL19579752

SCHEMBL19579752

CCOc1cc(C(=O)O)cc2c1ccn2CC(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.43
POLB P06746 4/20 0.38
CASP6 P55212 1/20 0.38
ALOX15 P16050 1/20 0.38
HTT P42858 1/20 0.38
LMNA P02545 2/20 0.36
MRGPRX4 Q96LA9 1/20 0.36
ASH1L Q9NR48 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MEN1 O00255 1/20 0.36
GAA P10253 1/20 0.36
KMT2A Q03164 1/20 0.36
MCL1 Q07820 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
PPARD Q03181 1/20 0.35
MAPK1 P28482 1/20 0.34
RXRA P19793 2/20 0.34
KDM4E B2RXH2 1/20 0.34
HNF4A P41235 1/20 0.34
RXRB P28702 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19579750 0.89 TSHR (0.48) TSHRPOLBCASP6ALOX15HTT
SCHEMBL19579762 0.84 RXRA (0.41) TSHRHTTMRGPRX4L3MBTL1RXRA
SCHEMBL309464 0.77 TSHR (0.47) TSHRPOLBCASP6ALOX15HTT
SCHEMBL309984 0.77 TUBB4A (0.50) TSHRHTTMEN1KMT2AKDM4E
SCHEMBL6870182 0.76 POLB (0.43) TSHRPOLBLMNAL3MBTL1MEN1
SCHEMBL308422 0.74 TSHR (0.44) TSHRPOLBCASP6ALOX15HTT
SCHEMBL19579741 0.73 TUBB4A (0.42) KMT2ARXRARXRBRXRGS1PR1
SCHEMBL16899563 0.68 RHEB (0.48) TSHRPOLBKMT2AKDM4E
SCHEMBL7920896 0.68 PLA2G4A (0.46) PPARD
SCHEMBL31363930 0.68 ASH1L (0.37) ASH1LMEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10849881-B2 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl HOFFMANN-LA ROCHE INC. (US) 2020-12-01 US disclosed
US-20180280352-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL HOFFMANN-LA ROCHE INC. (US) 2018-10-04 US disclosed
EP-3074400-B1 OCTAHYDRO-CYCLOBUTA [1,2-C;3,4-C']DIPYRROLE DERIVATIVES AS AUTOTAXIN INHIBITORS HOFFMANN LA ROCHE (CH) 2017-11-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180280352-A1 OCTAHYDRO-CYCLOBUTA[1,2-c;3,4-c']DIPYRROL-2-YL NPY1R, NPY2R, DECR1 TSHR 1399/4885POLB 482/4885CASP6 3420/4885
US-10849881-B2 Octahydro-cyclobuta[1,2-c;3,4-c′]dipyrrol-2-yl NPY1R, NPY2R, DECR1 TSHR 1463/4885POLB 486/4885CASP6 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.